LENZ Therapeutics, Inc.
LENZ
$28.00
$0.692.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 202.17M | 209.52M | 193.98M | 209.03M | 217.11M |
| Total Receivables | 1.10M | 1.30M | -- | -- | -- |
| Inventory | 949.00K | -- | -- | -- | -- |
| Prepaid Expenses | 2.78M | 2.67M | 3.77M | 2.77M | 3.48M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 114.00K | 114.00K | 114.00K | 114.00K |
| Total Current Assets | 207.00M | 213.60M | 197.86M | 211.92M | 220.70M |
|
|
|||||
| Total Current Assets | 207.00M | 213.60M | 197.86M | 211.92M | 220.70M |
| Net Property, Plant & Equipment | 2.11M | 2.13M | 2.00M | 1.99M | 1.91M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.60M | 1.60M | 1.40M | 1.40M | 1.40M |
| Total Assets | 210.70M | 217.33M | 201.25M | 215.30M | 224.01M |
|
|
|||||
| Total Accounts Payable | 4.32M | 2.85M | 3.66M | 4.26M | 2.76M |
| Total Accrued Expenses | 11.50M | 7.06M | 4.40M | 5.58M | 4.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 493.00K | 482.00K | 509.00K | 567.00K | 625.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 16.32M | 10.40M | 8.57M | 10.41M | 7.71M |
|
|
|||||
| Total Current Liabilities | 16.32M | 10.40M | 8.57M | 10.41M | 7.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 461.00K | 569.00K | 673.00K | 814.00K | 953.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 64.00K |
| Total Liabilities | 16.78M | 10.97M | 9.24M | 11.22M | 8.73M |
|
|
|||||
| Common Stock & APIC | 384.95M | 380.87M | 351.52M | 348.90M | 347.12M |
| Retained Earnings | -191.25M | -174.55M | -159.63M | -145.01M | -132.36M |
| Treasury Stock & Other | 227.00K | 38.00K | 123.00K | 196.00K | 523.00K |
| Total Common Equity | 193.93M | 206.37M | 192.01M | 204.08M | 215.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 193.93M | 206.37M | 192.01M | 204.08M | 215.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 193.93M | 206.37M | 192.01M | 204.08M | 215.28M |
|
|
|||||